Provided by Tiger Fintech (Singapore) Pte. Ltd.

DICE Therapeutics, Inc.

47.55
0.0000
Volume:- -
Turnover:206.51M
Market Cap:2.27B
PE:-20.24
High:47.55
Open:47.55
Low:47.55
Close:47.55
Loading ...
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2022

Major Issues Report

8-K - Current report
Mar 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 21, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 28, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Sep 27, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Sep 27, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Sep 15, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 09, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 09, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 27, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 27, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 25, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933